Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies



Rating:

Share or cite this content

Citations should be made in the following way:
H. Marshall (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), A. Biancardi (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), J. Astley (Sheffield, United Kingdom), R. Munro (Sheffield, United Kingdom), S. Rajaram (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), J. Bray (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), L. Armstrong (Sheffield, United Kingdom), L. Hardaker (York, United Kingdom), T. Fihn-Wikander (Gothenburg, Sweden), R. Hughes (Cambridge, United Kingdom), J. Wild (Sheffield, United Kingdom). A comparison of 129Xe MRI and advanced lung function testing in patients with asthma and /or COPD: The NOVELTY ADPro substudy. 1872

Member's Comments

No comment yet.

Related content which might interest you: Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Bronchodilator treatment response mapping in COPD using hyperpolarised gas ventilation MRI Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Measurement of lung function deterioration in COPD by V/P SPECT Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Comparison between spirometry and computed tomography to evaluate dynamic hyperinflation in COPD patients Source: International Congress 2014 – Functional imaging Year: 2014 Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 3D PREFUL: Novel high resolution dynamic lung ventilation imaging in patients with asthma, cystic fibrosis and COPD and healthy volunteers Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020 Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 The utility of vibration response imaging for calculation of ppoFEV1 and ppoDL,CO in patients with lung cancer referred for resection – The influence of coexisting COPD Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome Year: 2013 Quantifying lung function in COPD with hyperpolarised 3He MRI Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Relationships between COPD assessment test score and pulmonary function tests or quantitative CT analysis in Japanese COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 The long-term functional changes in COPD patients effected to the ionization radiation Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Chest CT scans obtained in multicentre clinical routine assessments are sufficient to develop a prediction function for emphysema from lung function Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 LATE-BREAKING ABSTRACT: Evaluating dynamic oxygen-enhanced MRI biomarkers of lung function: Sensitivity to conventional COPD treatment Source: Annual Congress 2013 –Functional imaging Year: 2013